Abstract
Scleroderma is associated with intractable hand pain from vasospasm, digital ischemia, tenosynovitis, and nerve entrapment. This study investigated the effect of hydrodissection of the carpal tunnel followed by corticosteroid injection for the painful scleroderma hand. Twenty-six consecutive subjects [12 with painful scleroderma hand and 14 with rheumatoid arthritis and carpal tunnel syndrome (RA/CTS)] underwent sonographically observed carpal tunnel hydrodissection with 3 ml of 1% lidocaine administered with a 25-gauge 1-in. needle on a 3-ml RPD mechanical syringe (reciprocating procedure device). After hydrodissection, a syringe exchange was performed, and 80 mg of triamcinolone acetonide was injected. Baseline pain, procedural pain, pain at outcome, responders, therapeutic duration, and reinjection interval were determined. Hydrodissection and injection with corticosteroid significantly reduced pain scores by 67% in scleroderma (p < 0.001) and by 47% in RA/CT (p < 0.001). Scleroderma and RA/CTS were similar in outcome measures: injection pain (p = 0.47), pain scores at outcome (p = 0.13), responders (scleroderma, 83.3%; RA/CTS, 57.1%, p = 0.15), pain at 6 months (p = 0.15), and therapeutic duration (p = 0.07). Scleroderma patients responded better in time to next injection (scleroderma, 8.5 ± 3.0 months; RA/CTS, 5.2 ± 3.1 months, p = 0.03). Reduced Raynaud’s attacks and healing of digital ulcers occurred in 83% of subjects. There were no complications. Hydrodissection with lidocaine followed by injection of triamcinolone reduces pain and vasomotor changes in the scleroderma hand. The mechanism may be a combination of hydrodissection-mediated mechanical freeing of entrapped arteries, nerves, and tendinous structures and corticosteroid-induced reduction of inflammatory vasospasm.
Similar content being viewed by others
References
Cuomo G, Zappia M, Abignano G, Iudici M, Rotondo A, Valentini G (2009) Ultrasonographic features of the hand and wrist in systemic sclerosis. Rheumatol Oxf 48:1414–1417
Avouac J, Walker U, Tyndall A, Kahan A et al (2010) Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol 37:1488–1501
Tagliafico A, Panico N, Serafini G, Ghio M, Martinoli C (2010) The thickness of the A1 pulleys reflects the disability of hand mobility in scleroderma. A pilot study using high-frequency ultrasound. Eur J Radiol. doi:10.1016/j.ejrad.2010.05.013
Dhillon S (2009) Bosentan: a review of its use in the management of digital ulcers associated with systemic sclerosis. Drugs 69:2005–2024
Fregene A, Ditmars D, Siddiqui A (2009) Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon. J Hand Surg Am 34:446–452
Hashem M, Lewis R (2007) Successful long-term treatment of a patient with long-standing Raynaud’s disease by an extradural bupivacaine block. Anaesth Intensive Care 35:618–619
Sylaidis P, Logan A (1997) Local injection of phentolamine to treat digital ischaemic necrosis in Raynaud's syndrome. J Wound Care 6:356–357
Willerson JT, Thompson RH, Hookman P, Herdt J, Decker JL (1970) Reserpine in Raynaud's disease and phenomenon. Short-term response to intra-arterial injection. Ann Intern Med 72:17–27
Jones NF, Imbriglia JE, Steen VD, Medsger TA (1987) Surgery for scleroderma of the hand. J Hand Surg Am 12:391–400
Tomaino MM, Goitz RJ, Medsger TA (2001) Surgery for ischemic pain and Raynaud’s phenomenon in scleroderma: a description of treatment protocol and evaluation of results. Microsurgery 21:75–79
Klyscz T, Jünger M, Meyer H, Rassner G (1998) Improvement of acral circulation in a patient with systemic sclerosis with stellate blocks. VASA 27:39–42
Mondelli M, Romano C, De Stefano R, Cioni R (2000) Nerve conduction velocity study of the upper limb in Raynaud’s phenomenon. Rheumatol Int 19:165–169
Pal B, Keenan J, Misra HN, Moussa K, Morris J (1996) Raynaud's phenomenon in idiopathic carpal tunnel syndrome. Scand J Rheumatol 25:143–145
Medsger TA Jr (2003) Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am 29:255–273
Tagliafico A, Panico N, Resmini E, Derchi LE, Ghio M, Martinoli C (2010) The role of ultrasound imaging in the evaluation of peripheral nerve in systemic sclerosis (scleroderma). Eur J Radiol. doi:10.1016/j.ejrad.2009.08.010
Smith J, Wisniewski SJ, Finnoff JT, Payne JM (2008) Sonographically guided carpal tunnel injections: the ulnar approach. J Ultrasound Med 27:1485–1490
Grassi W, Farina A, Filippucci E, Cervini C (2002) Intralesional therapy in carpal tunnel syndrome: a sonographic-guided approach. Clin Exp Rheumatol 20:73–76
McNally E (2005) Musculoskeletal interventional ultrasound. In: McNally E (ed) Practical musculoskeletal ultrasound. Elsevier, New York, pp 293–294
Gimbel HV (1994) Hydrodissection and hydrodelineation. Int Ophthalmol Clin 34:73–90
Mejia R, Saxena P, Tam RK (2005) Hydrodissection in redo sternotomies. Ann Thorac Surg 79:363–364
Sibbitt WL Jr, Peisajovich A, Michael AA, Park KS, Sibbitt RR, Band PA, Bankhurst AD (2009) Does sonographic guidance influence the outcome of intraarticular injections? J Rheumatol 36:1892–1902
Moorjani GR, Bedrick EJ, Michael AA, Peisjovich A, Sibbitt WL Jr, Bankhurst AD (2008) Integration of safety technologies into rheumatology and orthopedic practices: a randomized, controlled trial. Arthritis Rheum 58:1907–1914
Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, Choquette D, Raymond Y, Senécal JL (2001) Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 44:735–736
The American College of Rheumatology (1980) Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 23:581–590
Miller MD, Ferris DG (1993) Measurement of subjective phenomena in primary care research: the Visual Analogue Scale. Fam Pract Res J 13:15–24
Katz J, Melzack R (1999) Measurement of pain. Surg Clin North Am 79:231–252
Moorjani GR, Michael AA, Peisjovich A, Park KS, Sibbitt WL Jr, Bankhurst AD (2008) Patient pain and tissue trauma during syringe procedures: a randomized controlled trial. J Rheumatol 35:1124–1129
Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, Healey LA, Kaplan SR, Liang MH, Luthra HS et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315–324
El Miedany Y, Ashour S, Youssef S, Mehanna A, Meky FA (2008) Clinical diagnosis of carpal tunnel syndrome: old tests—new concepts. Joint Bone Spine 75:451–457
Wilder-Smith EP, Seet RC, Lim EC (2006) Diagnosing carpal tunnel syndrome—clinical criteria and ancillary tests. Nat Clin Pract Neurol 2:366–374
Sibbitt WL Jr, Sibbitt RR, Michael AA, Fu DI, Draeger HT, Twining JM, Bankhurst AD (2006) Physician control of needle and syringe during traditional aspiration–injection procedures with the new reciprocating syringe. J Rheumatol 33:771–778
Sibbitt RR, Sibbitt WL Jr, Nunez SE, Kettwich LG, Kettwich SC, Bankhurst AD (2006) Control and performance characteristics of eight different suction biopsy devices. J Vasc Interv Radiol 17:1657–1669
Mouthon L, Mestre-Stanislas C, Berezne A, Rannou F, Guilpain P, Revel M et al (2010) Impact of digital ulcers on disability and health-related quality of life in systemic sclerosis. Ann Rheum Dis 69:214–217
Ly-Pen D, Andreu JL, de Blas G, Sanchez-Olaso A (2005) Millan I (2005) Surgical decompression versus local steroid injection in carpal tunnel syndrome: a one-year, prospective, randomized, open, controlled clinical trial. Arthritis Rheum 52:612–619
Keith MA (1957) Acroparaesthesiae in sclerodactyly and carpal tunnel syndrome treated with prednisolone. Scott Med J 2:435–438
Kasten SJ, Louis DS (1996) Carpal tunnel syndrome: a case of median nerve injection injury and a safe and effective method for injecting the carpal tunnel. J Fam Pract 43:79–82
Frederick HA, Carter PR, Littler JW (1992) Injection injuries to the median and ulnar nerves at the wrist. J Hand Surg Am 17:645–647
Payne JM, Brault JS (2008) Digital ischemia after carpal tunnel injection: a case report. Arch Phys Med Rehabil 89:1607–1610
Cherasse A, Kahn MF, Mistrih R, Maillard H, Strauss J, Tavernier C (2003) Nicolau's syndrome after local glucocorticoid injection. Joint Bone Spine 70:390–392
Friedman SJ, Butler DF, Pittelkow MR (1988) Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. Report of two cases and review of the literature. J Am Acad Dermatol 19:537–541
Derendorf H, Möllmann H, Grüner A, Haack D, Gyselby G (1986) Pharmacokinetics and pharmacodynamics of glucocorticoid suspensions after intra-articular administration. Clin Pharmacol Ther 39:313–317
Frey BM, Walker C, Frey FJ, de Weck AL (1984) Pharmacokinetics and pharmacodynamics of three different prednisolone prodrugs: effect on circulating lymphocyte subsets and function. J Immunol 33:2479–2487
Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, Noël LH, Trolliet P, Frances C, Cabane J, Guillevin L, Group Français de Recherche sur le Sclérodermie (GFRS) (2008) Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis 67:110–116
Steen VD, Medsger TA Jr (1998) Case-control study of corticosteroids and other drugs that either precipitate or protect from the development of scleroderma renal crisis. Arthritis Rheum 41:1613–1619
Sellevold OF, Jynge P (1987) Steroids and cardioplegia: effects of glucocorticoids upon vascular resistance during cardioplegic perfusion. Thorac Cardiovasc Surg 35:307–311
Disclosures
There was no industry support for this research. All devices and drugs were purchased, not donated to this study. Drs. Chavez-Chiang, Norton, DeLea, and Poole have no disclosures. Dr. Bankhurst is funded by a research grant from the Robert Wood Johnson Foundation. Dr. Wilmer L. Sibbitt, Jr. is funded by research grant RO1 HLO77422-01-A3 from the US National Institutes of Health and is an employee of the University of New Mexico. Dr. W. Sibbitt also is an expert consultant for Becton Dickinson, Inc., Intelligence Management Solutions, Inc., Ferring Pharmaceuticals, Inc., Avanca Medical Devices, Inc., Avasca Medical, Inc., and MediTech Duopross, Inc. Dr. Sibbitt holds stock in Apple Inc., Celgene Corp, Inc., Avanca, Inc., Avasca, Inc., Sun Microsystems, Inc, Symantec Corp., and Java, Inc. In the preceding 12 months, Dr. Sibbitt has had four patents acquired by Abbott Vascular, Inc., but these patents do not relate to the present research.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
DeLea, S.L., Chavez-Chiang, N.R., Poole, J.L. et al. Sonographically guided hydrodissection and corticosteroid injection for scleroderma hand. Clin Rheumatol 30, 805–813 (2011). https://doi.org/10.1007/s10067-010-1653-6
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10067-010-1653-6